Research
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
-
* Corresponding author: Jean-Louis Vincent jlvincent@ulb.ac.be
Critical Care 2006, 10:R120 doi:10.1186/cc5026
No comments have yet been made on this article.